More Company News

Scancell

Phase 2 SCIB1 trial expanded
15 Jun 2022Read More

Scancell

First patient dosed in Modi-1 Phase 1
13 Jun 2022Read More

Scancell

Modi-1 Phase 1/2 trial open for recruitment
11 Apr 2022Read More

Scancell

Update on COVIDITY trial
29 Mar 2022Read More

Scancell

Scancell progresses its new anti-glycan mAb
17 Mar 2022Read More

Scancell

Update on COVIDITY Phase I trial
31 Jan 2022Read More

Scancell

Interim results to 31 October 2021
26 Jan 2022Read More

Scancell

First patient dosed in SCIB1 Phase II trial
19 Nov 2021Read More

Scancell

Results for the year ended 30 April 2021
29 Oct 2021Read More

Scancell

First subject dosed in South Africa Phase I COVIDITY trial
05 Oct 2021Read More

1 2 3 4 … 7
Return to Scancell
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).